|
1）Fujimura K, Wakino S, Minakuchi H, et al. Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice. PLoS One. 2014; 9: e94373
|
|
|
|
2）Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009; 6: 343-52
|
|
|
|
|
3）Dixit VD, Yang H, Cooper-Jenkins A, et al. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood. 2009; 113: 5202-5
|
|
|
|
|
|
4）Bayliss JA, Andrews ZB. Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection. Ther Adv Endocrinol Metab. 2013; 4: 25-36
|
|
|
|
|
|
5）Andrews ZB, Liu ZW, Walllingford N, et al. UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals. Nature. 2008; 454: 846-51
|
|
|
|
|
|
6）Takeda R, Nishimatsu H, Suzuki E, et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol. 2006; 17: 113-21
|
|
|
|
|
|
7）Wang W, Bansal S, Falk S, et al. Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol. 2009; 297: F1032-7
|
|
|
|
|
|
8）Kemp BA, Howell NL, Gray JT, et al. Intrarenal ghrelin infusion stimulates distal nephron-dependent sodium reabsorption in normal rats. Hypertension. 2011; 57: 633-9
|
|
|
|
|
|
9）Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009; 119: 524-30
|
|
|
|
|
|
10）Yu L, Noble NA, Border WA. Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol. 2002; 2: 177-81
|
|
|
|
|
|
11）Lutter M, Sakata I, Osborne-Lawrence S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci. 2008; 11: 752-3
|
|
|
|
|
|
12）Wynne K, Giannitsopoulou K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 2005; 16: 2111-8
|
|
|
|
|
|
13）Ashby DR, Ford HE, Wynne KJ, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 2009; 76: 199-20
|
|
|
|
|